// App-Quantinova.ai

BSH2020‐PO‐174 : Observational study of outcomes in patients with antiphospholipid syndrome anticoagulated with Rivaroxaban

Researchers

Presenter

  • T. W. Htut

Principal Investigators

  • D. Milne

  • M. M. Khan

  • H. G. Watson

Medical Centers

  • Department of Haematology, Aberdeen Royal Infirmary, Foresterhill Health Campus, Aberdeen, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Autoimmune (AI)

  • Pulmonary/Respiratory Diseases

  • Central Nervous System (CNS)

  • Gastroenterology (GU)

  • Obstetrics/Gynecology

  • Genetic Disorder

Disease

  • Antiphospholipid syndrome

  • Gastrointestinal bleeding

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

  • Ischemic stroke

  • Stroke

  • Lupus

  • Tumor necrosis factor receptor associated periodic syndrome

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Evithrom

  • Warfarin

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved